思想流动 发表于 2025-3-25 05:39:35

http://reply.papertrans.cn/2/193/19221/19221-21.png

graphy 发表于 2025-3-25 09:34:04

http://reply.papertrans.cn/2/193/19221/19221-22.png

宏伟 发表于 2025-3-25 11:58:54

http://reply.papertrans.cn/2/193/19221/19221-23.png

sulcus 发表于 2025-3-25 18:31:02

Submitted on: 24 July 2002.
Revised on: 30 October 2002.
Accepted on: 05 December 2002.

___________________Journal of Scleroderma and Related Disorders

Anticoagulant 发表于 2025-3-25 22:05:27

http://reply.papertrans.cn/2/193/19221/19221-25.png

急性 发表于 2025-3-26 01:03:01

http://reply.papertrans.cn/2/193/19221/19221-26.png

Lasting 发表于 2025-3-26 04:54:04

http://reply.papertrans.cn/2/193/19221/19221-27.png

改良 发表于 2025-3-26 08:55:45

Submitted on: 06 April 2007.
Revised on: 02 July 2007.
Accepted on: 16 July 2007.

___________________Journal of Scleroderma and Related Disorders

mutineer 发表于 2025-3-26 13:10:18

http://reply.papertrans.cn/2/193/19221/19221-29.png

Hypomania 发表于 2025-3-26 18:43:42

http://reply.papertrans.cn/2/193/19221/19221-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Journal of Scleroderma and Related Disorders 2024/2025影响因子:1.425 (J SCLERODERMA RELAT) (2397-1983). (RHEUMATOLOGY